Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 2/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.61 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.61 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.61 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.61 |
| ▸ | GGT1 | P19440 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2761803 | 0.89 | KDM4E (0.67) | CFDKDM4EHSD17B10ALDH1A1TSHR | |
| SCHEMBL789388 | 0.89 | PTGDR2 (0.63) | CFDKDM4EHSD17B10ALDH1A1TSHR | |
| SCHEMBL3382142 | 0.85 | CFD (0.54) | CFDKDM4EHSD17B10ALDH1A1TSHR | |
| SCHEMBL16715329 | 0.85 | CFD (1.00) | CFDKDM4EHSD17B10ALDH1A1TSHR | |
| SCHEMBL3453790 | 0.84 | TSHR (0.58) | CFDKDM4EHSD17B10ALDH1A1TSHR | |
| SCHEMBL1603859 | 0.84 | HSD17B10 (0.58) | CFDKDM4EHSD17B10ALDH1A1TSHR | |
| SCHEMBL3284810 | 0.84 | CFD (0.53) | CFDKDM4EHSD17B10ALDH1A1TSHR | |
| SCHEMBL344489 | 0.83 | CFD (0.71) | CFDKDM4EHSD17B10ALDH1A1TSHR | |
| SCHEMBL344505 | 0.83 | KDM4E (0.74) | CFDKDM4EHSD17B10ALDH1A1TSHR | |
| SCHEMBL1317371 | 0.83 | CFD (0.71) | CFDKDM4EHSD17B10ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2841066-B1 | ANTI-INFLUENZA AGENT CONJUGATED TO ANTI-INFLAMMATORY AGENT | ACADEMIA SINICA (TW) | 2021-02-17 | — | — | EP | claimed |
| US-10758626-B2 | Polymer conjugate comprising a bioactive agent | POLYACTIVA PTY LTD (AU) | 2020-09-01 | — | — | US | claimed |
| EP-3524272-A1 | ENHANCED ANTI-INFLUENZA AGENTS CONJUGATED WITH ANTI-INFLAMMATORY ACTIVITY | Academia Sinica (TW) | 2019-08-14 | — | — | EP | claimed |
| US-20180303948-A1 | POLYMER CONJUGATE COMPRISING A BIOACTIVE AGENT | POLYACTIVA PTY LTD (AU) | 2018-10-25 | — | — | US | claimed |
| EP-3347052-A1 | POLYMER CONJUGATE COMPRISING A BIOACTIVE AGENT | Polyactiva Pty Ltd (AU) | 2018-07-18 | — | — | EP | claimed |
| US-9968684-B2 | Polymer-NSAID conjugate | POLYACTIVA PTY LTD (AU) | 2018-05-15 | — | — | US | claimed |
| EP-2863921-B1 | POLYMER-NSAID CONJUGATE | POLYACTIVA PTY LTD (AU) | 2018-04-18 | — | — | EP | claimed |
| WO-2017041142-A1 | POLYMER CONJUGATE COMPRISING A BIOACTIVE AGENT | POLYACTIVA PTY LTD (AU) | 2017-03-16 | — | — | WO | claimed |
| US-20150328323-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | SATYAM APPARAO (IN) | 2015-11-19 | — | — | US | claimed |
| US-20150150999-A1 | POLYMER-NSAID CONJUGATE | POLYACTIVA PTY LTD (AU) | 2015-06-04 | — | — | US | claimed |
| WO-2004005313-A2 | HYBRID MOLECULES OF MACROLIDES WITH STEROID/NON-STEROID ANTI-INFLAMMATORY, ANTINEOPLASTIC AND ANTIVIRAL ACTIVE MOLECULES | PLIVA - ISTRAZIVACKI INSTITUT D.O.O. (US) | 2004-01-15 | — | — | WO | claimed |
| WO-2004005309-A2 | NOVEL NONSTEROIDAL ANTI-INFLAMMATORY SUBSTANCES, COMPOSITIONS AND METHODS FOR THEIR USE | PLIVA - ISTRAZIVACKI INSTITUT D.O.O. (US) | 2004-01-15 | — | — | WO | claimed |
| US-20030235617-A1 | Pharmaceutical dosage form for mucosal delivery | MCNEIL-PPC, INC | 2003-12-25 | — | — | US | claimed |
| US-20030180357-A1 | Pharmaceutical tablet | MCNEIL-PPC, INC | 2003-09-25 | — | — | US | claimed |
| CN-1433396-A | Pharmaceutical compounds | NICOX SA (FR) | 2003-07-30 | — | — | CN | claimed |
| EP-1324974-A2 | DRUGS FOR DIABETES | Nicox S.A. (FR) | 2003-07-09 | — | — | EP | claimed |
| CN-1358178-A | Pharmaceutical compounds | NICOX SA (FR) | 2002-07-10 | — | — | CN | claimed |
| CN-1354740-A | Pharmaceutical compounds | NICOX SA (FR) | 2002-06-19 | — | — | CN | claimed |
| WO-2002030867-A2 | DRUGS FOR DIABETES | NICOX S.A. (FR) | 2002-04-18 | — | — | WO | claimed |
| US-5985927-A | Medicaments for the selective treatment of tumor tissues | KREUTZ WERNER (DE) | 1999-11-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030180357-A1 | Pharmaceutical tablet | GYPA, SORD, SRI | CFD 1375/4885KDM4E 3204/4885HSD17B10 2700/4885 |
| US-20150150999-A1 | POLYMER-NSAID CONJUGATE | PTGS1, PTGES3, PTGES | CFD 2303/4885KDM4E 3166/4885HSD17B10 209/4885 |
| US-10758626-B2 | Polymer conjugate comprising a bioactive agent | MSN, PAM, PARG | CFD 2900/4885KDM4E 3935/4885HSD17B10 3174/4885 |
| US-20180303948-A1 | POLYMER CONJUGATE COMPRISING A BIOACTIVE AGENT | MSN, PAM, PARG | CFD 2900/4885KDM4E 3935/4885HSD17B10 3174/4885 |
| US-20030235617-A1 | Pharmaceutical dosage form for mucosal delivery | SI, UGGT1, GYPA | CFD 2954/4885KDM4E 2862/4885HSD17B10 1602/4885 |
| US-20150328323-A1 | Nitric Oxide Releasing Produgs of Therapeutic Agents | NOS2, NOS1, PTGIS | CFD 2417/4885KDM4E 3686/4885HSD17B10 1633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.